Cargando…

Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy

Objective: Previous studies consistently showed the interaction between Sirtuin 1 (SIRT1) and immune inflammation is significantly related to metabolic abnormalities, but their role in the pathogenesis of metabolic syndrome caused by second-generation antipsychotics (SGAs) in schizophrenia patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xinyu, Yu, Lingfang, Wang, Dandan, Chen, Yan, Wang, Yewei, Wu, Zenan, Liu, Ruimei, Ren, Juanjuan, Tang, Wei, Zhang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723842/ https://www.ncbi.nlm.nih.gov/pubmed/33324265 http://dx.doi.org/10.3389/fpsyt.2020.602121

Ejemplares similares

Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics
por: Liu, Ruimei, et al.
Publicado: (2022)

Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia
por: Wang, Dandan, et al.
Publicado: (2022)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2021)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia
por: Yin, Feiyan, et al.
Publicado: (2023)

Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
por: Zhang, Jinling, et al.
Publicado: (2023)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats
por: Wang, Yewei, et al.
Publicado: (2020)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
por: Mier, Daniela, et al.
Publicado: (2018)

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang, Xinyu, et al.
Publicado: (2019)

Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration
por: Weston-Green, Katrina, et al.
Publicado: (2018)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Metacognitive Training Modulates Default-Mode Network Homogeneity During 8-Week Olanzapine Treatment in Patients With Schizophrenia
por: Shan, Xiaoxiao, et al.
Publicado: (2020)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial
por: Deng, Mengling, et al.
Publicado: (2023)

Increased cortical structural covariance correlates with anhedonia in schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2023)

Clozapine Triggering Cecal Volvulus in a Patient With Malrotation and Schizophrenia: Side Effect That Needs Emphasis
por: Aneja, Jitender, et al.
Publicado: (2020)

Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
por: Vasiliu, Octavian
Publicado: (2022)

Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
por: Cordova, Victor Hugo Schaly, et al.
Publicado: (2023)

Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2014)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic
por: Ma, Botao, et al.
Publicado: (2023)

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine
por: Ma, Jun, et al.
Publicado: (2021)

Clinical Experience With Intramuscular Clozapine
por: Munzar, Benedikt, et al.
Publicado: (2021)

Case of Secondary Tics Associated With Olanzapine in an Adult
por: Mills, Eric W., et al.
Publicado: (2017)

Olanzapine-Associated Rhabdomyolysis: A Case Report
por: Skryabin, Valentin Y, et al.
Publicado: (2021)

Cytokine Alterations in Schizophrenia: An Updated Review
por: Momtazmanesh, Sara, et al.
Publicado: (2019)

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia
por: Pjevac, Milica, et al.
Publicado: (2023)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Olanzapine-Induced Parkinsonism and Akathisia: A Case Report
por: Jaitpal, Varun, et al.
Publicado: (2022)

Cigarette smoking, coffee consumption, alcohol intake, and clozapine metabolism: A Mendelian randomization study
por: Zeng, Lingsi, et al.
Publicado: (2022)

Prescription and Underprescription of Clozapine in Dutch Ambulatory Care
por: van der Zalm, Yvonne C., et al.
Publicado: (2018)

Clozapine-Induced Pneumonitis: A Case Report
por: Torrico, Tyler, et al.
Publicado: (2020)

Management of Clozapine Titration in the Setting of Cardiac Comorbidities
por: Bhamidipati, Theja, et al.
Publicado: (2021)

A Case Report of Excessive Use of Clozapine Combined With Clonazepam
por: Li, Wei, et al.
Publicado: (2022)

Efficacy of Adjunctive Treatments Added to Olanzapine or Clozapine for Weight Control in Patients with Schizophrenia: A Systematic Review and Meta-Analysis
por: Choi, Yun-Jung
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_us26n09se33f0t7hgqi3biqp8u